Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease.
about
Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic StrategiesThe Lymphotoxin Network: orchestrating a type I interferon response to optimize adaptive immunityGVHD after haploidentical transplantation: a novel, MHC-defined rhesus macaque model identifies CD28- CD8+ T cells as a reservoir of breakthrough T-cell proliferation during costimulation blockade and sirolimus-based immunosuppressionLTβR signaling in dendritic cells induces a type I IFN response that is required for optimal clonal expansion of CD8+ T cells.New strategies for prevention and treatment of graft-versus-host disease and for induction of graft-versus-leukemia effects.Herpesvirus entry mediator (TNFRSF14) regulates the persistence of T helper memory cell populations.The tumor necrosis factor superfamily of cytokines in the inflammatory myopathies: potential targets for therapy.Selective targeting of the LIGHT-HVEM costimulatory system for the treatment of graft-versus-host disease.Targeting lymphocyte activation through the lymphotoxin and LIGHT pathwaysTNF superfamily: costimulation and clinical applicationsCostimulatory and coinhibitory receptors in anti-tumor immunityThe unexpected role of lymphotoxin beta receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer development.Intervention with costimulatory pathways as a therapeutic approach for graft-versus-host disease.LTβR and CD40: working together in dendritic cells to optimize immune responses.LIGHT/HVEM/LTβR interaction as a target for the modulation of the allogeneic immune response in transplantation.T-cell costimulatory molecules in acute-graft-versus host disease: therapeutic implications.Dynamic changes in serum cytokine levels and their clinical significance in predicting acute GVHD.Tumor necrosis factor receptor 1 expression is upregulated in dendritic cells in patients with chronic HCV who respond to therapy.Induction and effector phase of allergic lung inflammation is independent of CCL21/CCL19 and LT-beta.Expression of lymphotoxin-alphabeta on antigen-specific T cells is required for DC function.CD28 Blockade Ex Vivo Induces Alloantigen-Specific Immune Tolerance but Preserves T-Cell Pathogen Reactivity.The capacity of the TNF family members 4-1BBL, OX40L, CD70, GITRL, CD30L and LIGHT to costimulate human T cellsLIGHT is dispensable for CD4+ and CD8+ T cell and antibody responses to influenza A virus in mice.
P2860
Q26751959-5AF95F34-1BE0-4992-A288-0A7972C6C862Q27025082-41268FD4-5C86-43C5-825F-18377FFE68BAQ34450497-C2B6E62F-D605-4F4E-BF04-FDEC2145D90DQ34549822-5198CB02-583B-425F-B85A-8D4053594CADQ35060005-46D66884-6A77-4CAB-973B-D4F740409086Q35102246-7CDCDA94-55B8-4A34-B504-DBE4663D48A5Q35450066-E314ACB4-E970-4394-9E91-38C3DBCC7F25Q35804422-293A4907-B9F0-454B-BB12-5C456AF8A929Q37036159-B6EC4145-62F4-4DFD-A625-485782187C09Q37266849-7913D79E-7680-4794-B274-0469D33D643DQ37474920-966D27C0-D5BB-409B-B141-8BE1ADD2F190Q37770209-4D47775F-5538-4238-83E2-42768EAC07E0Q37785736-84463501-F2B1-4503-8584-02503C2DBA61Q37948123-E5E7BD8D-3265-4B2B-9795-3B5D6CACAF2AQ38077275-007C786C-0171-44E2-B517-1BCAF40DE7D2Q38730256-14D9EE7C-2CAB-4E17-B85E-9427284D891EQ41593355-0C74B613-C9DE-40C9-B246-FBB9B490F820Q41678413-EDB5E8E5-A883-41F7-8113-DC310707D267Q41831341-84C3E9C3-9180-4F86-9572-CB65F939FB42Q41905092-E7D18AF5-BC62-468B-AA1B-278FABA62FFBQ41916538-02DAE6C5-F191-4C8F-8D82-BF0055C81145Q41947504-51FF56A2-7108-4505-9F2C-94ECFCE5A8B5Q45418398-39FAD76B-E7F9-410C-BF56-E64F08D70A96
P2860
Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Blockade of LIGHT/LTbeta and C ...... ing graft-versus-host disease.
@ast
Blockade of LIGHT/LTbeta and C ...... ing graft-versus-host disease.
@en
Blockade of LIGHT/LTbeta and C ...... ing graft-versus-host disease.
@nl
type
label
Blockade of LIGHT/LTbeta and C ...... ing graft-versus-host disease.
@ast
Blockade of LIGHT/LTbeta and C ...... ing graft-versus-host disease.
@en
Blockade of LIGHT/LTbeta and C ...... ing graft-versus-host disease.
@nl
prefLabel
Blockade of LIGHT/LTbeta and C ...... ing graft-versus-host disease.
@ast
Blockade of LIGHT/LTbeta and C ...... ing graft-versus-host disease.
@en
Blockade of LIGHT/LTbeta and C ...... ing graft-versus-host disease.
@nl
P2093
P2860
P356
P1476
Blockade of LIGHT/LTbeta and C ...... ing graft-versus-host disease.
@en
P2093
Dallas Flies
Esteban Celis
Hideto Tamura
Koji Tamada
Larry R Pease
Lieping Chen
Yang-Xin Fu
P2860
P304
P356
10.1172/JCI0213604
P407
P577
2002-02-01T00:00:00Z